NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 703315 | Null | 0.00293992674122322 | 0.28898748 |
NSC 703318 | Null | 0.00293992674122322 | 0.33205116 |
NSC 709564 | Null | 0.00293992674122322 | 0.37469386 |
NSC 720326 | 2-(5,6,7-Trimethoxyindol-2-carbonyl)amino-4H-pyrazolo[1,5-a] indole | 0.00293992674122322 | 0.39274859 |
NSC 722985 | Null | 0.00293992674122322 | 0.468821 |
NSC 724780 | (1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 | 0.00293992674122322 | 0.40131147 |
NSC 728040 | 2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline | 0.00293992674122322 | 0.2333115 |
NSC 743432 | 2-{5-[4-(5-{4-[6-morpholino-1H-benzo[d]imidazole-2-yl]phenoxy}pentyl)piperazino]pentyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione | 0.00293992674122322 | 0.50015885 |
NSC 287459 | Cytarabine AY | 0.00352002370824893 | 0.35252316 |
NSC 659609 | Null | 0.00352002370824893 | 0.40437649 |